Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer
NCT00340847 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2017-07-02
Summary
The proposed research intends to construct a set of tissue microarrays containing different types of normal and lung cancer tissues for the study of genes associated with lung cancer. Thus far we have generated a lung cancer tissue arrayusing paraffin embedded archival tissues from 300 lung turmors tissues and 100 adjacent normal tissues. Four- micrometer thickness sections have been cut from the tissue array and were used to survey gene expression status in arrayed tumors using immunohistochemistry methody. We are currently performing IHC studies ot 1) determine protein expression and its correlation with gene expression patterms ovserved using cDNA arrays. 2) Analyze protein expression in the chromosome remodeling pathyway in non-small cell lung cancer. And 3) determine the association of gene expression with lung tumor stage and clinical outcome. The current protocol is needed to complete the above studies and for the production of neuroendocrine tumors.
Conditions
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-08-09
- Completion
- 2010-05-19
Countries
- United States
Study Locations
More Related Trials
-
Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer
NCT00923884 ·Status: COMPLETED
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
NCT03851445 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer
NCT00897143 ·Status: WITHDRAWN
-
Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants
NCT00899457 ·Status: COMPLETED
-
DNA Chip Based Prognosis of Lung Cancer
NCT00973427 ·Status: COMPLETED
-
Establishing a Longitudinal Cohort Study of Lung Cancer Using Tissue and Peripheral Blood Metabolomics.
NCT06843707 ·Status: RECRUITING
-
Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA
NCT02833467 ·Status: UNKNOWN
-
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
NCT01580982 ·Status: RECRUITING
-
Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes
NCT06699979 ·Status: RECRUITING
-
Predictive Gene Profiles and Dynamic Measurement of Treatment Response in Metastatic Non-small Cell Lung Cancer
NCT03512847 ·Status: COMPLETED
-
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
NCT00003006 ·Status: COMPLETED
-
NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy
NCT04636047 ·Status: UNKNOWN
-
Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer
NCT04814407 ·Status: RECRUITING
-
Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)
NCT01173458 ·Status: COMPLETED
-
NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"
NCT03771404 ·Status: UNKNOWN ·Phase: NA
-
Detection of Genetic Markers of Lung Cancer
NCT00280202 ·Status: RECRUITING
-
Lung Tumor Protein Synthesis Rates in Lung Cancer Patients
NCT05794529 ·Status: RECRUITING
-
Characterization of Methylation Patterns in Lung Cancer
NCT02373917 ·Status: COMPLETED
-
A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer
NCT04254497 ·Status: COMPLETED
-
Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment
NCT03244904 ·Status: UNKNOWN
-
Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA
NCT03499678 ·Status: TERMINATED
-
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations
NCT05701787 ·Status: RECRUITING
-
Lung Cancer Early Molecular Assessment Trial
NCT02894853 ·Status: UNKNOWN
-
To Establish a Molecular Typing System for Early Diagnosis of Lung Cancer
NCT05432128 ·Status: RECRUITING